204 related articles for article (PubMed ID: 29658542)
21. Integrating Omic Technologies in Alzheimer's Disease.
Avramouli A; Vlamos PM
Adv Exp Med Biol; 2017; 987():177-184. PubMed ID: 28971457
[TBL] [Abstract][Full Text] [Related]
22. Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine.
Frédérich M; Pirotte B; Fillet M; de Tullio P
J Med Chem; 2016 Oct; 59(19):8649-8666. PubMed ID: 27295417
[TBL] [Abstract][Full Text] [Related]
23. Causality at the dawn of the 'omics' era in medicine and in nephrology.
Zoccali C; Brancaccio D; Nathan MJ
Nephrol Dial Transplant; 2016 Sep; 31(9):1381-5. PubMed ID: 27190363
[TBL] [Abstract][Full Text] [Related]
24. Metabolomics Applications in Precision Medicine: An Oncological Perspective.
Puchades-Carrasco L; Pineda-Lucena A
Curr Top Med Chem; 2017; 17(24):2740-2751. PubMed ID: 28685691
[TBL] [Abstract][Full Text] [Related]
25. Precision Medicine in Myelodysplastic Syndromes and Leukemias: Lessons from Sequential Mutations.
Nazha A; Sekeres MA
Annu Rev Med; 2017 Jan; 68():127-137. PubMed ID: 27618752
[TBL] [Abstract][Full Text] [Related]
26. [Precision medicine: new opportunities and challenges for molecular epidemiology].
Song J; Hu Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Apr; 37(4):587-92. PubMed ID: 27087232
[TBL] [Abstract][Full Text] [Related]
27. Watson for Genomics: Moving Personalized Medicine Forward.
Rhrissorrakrai K; Koyama T; Parida L
Trends Cancer; 2016 Aug; 2(8):392-395. PubMed ID: 28741491
[TBL] [Abstract][Full Text] [Related]
28. The cell secretome in personalized and regenerative medicine.
Salgado AJ; Gimble JM; Costa BM
Biochimie; 2018 Dec; 155():1. PubMed ID: 30419261
[No Abstract] [Full Text] [Related]
29. Promoting new concepts of skincare via skinomics and systems biology-From traditional skincare and efficacy-based skincare to precision skincare.
Jiang B; Jia Y; He C
J Cosmet Dermatol; 2018 Dec; 17(6):968-976. PubMed ID: 29749695
[TBL] [Abstract][Full Text] [Related]
30. Clinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic Era.
Tebani A; Abily-Donval L; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447622
[TBL] [Abstract][Full Text] [Related]
31. Public health and precision medicine share a goal.
Vaithinathan AG; Asokan V
J Evid Based Med; 2017 May; 10(2):76-80. PubMed ID: 28276633
[TBL] [Abstract][Full Text] [Related]
32. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine.
Kohler I; Hankemeier T; van der Graaf PH; Knibbe CAJ; van Hasselt JGC
Eur J Pharm Sci; 2017 Nov; 109S():S15-S21. PubMed ID: 28502671
[TBL] [Abstract][Full Text] [Related]
33. Multi-omic data integration and analysis using systems genomics approaches: methods and applications in animal production, health and welfare.
Suravajhala P; Kogelman LJ; Kadarmideen HN
Genet Sel Evol; 2016 Apr; 48(1):38. PubMed ID: 27130220
[TBL] [Abstract][Full Text] [Related]
34. Guest Editorial- special issue on ‘-omics’ based companion diagnostics for personalized medicine.
Chen J; Subramaniam S; Wishart D; Wong S
IEEE Trans Biomed Circuits Syst; 2014 Feb; 8(1):1-3. PubMed ID: 24809069
[No Abstract] [Full Text] [Related]
35. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
36. How Can Omic Science be Improved?
Simons K
Proteomics; 2018 Mar; 18(5-6):e1800039. PubMed ID: 29417741
[TBL] [Abstract][Full Text] [Related]
37. Here come the omics!
Grayson MH; Marshall GD
Ann Allergy Asthma Immunol; 2019 Dec; 123(6):531. PubMed ID: 31761011
[No Abstract] [Full Text] [Related]
38. Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine.
Goodman SR; Pace BS; Hansen KC; D'alessandro A; Xia Y; Daescu O; Glatt SJ
Exp Biol Med (Maywood); 2016 Apr; 241(7):772-81. PubMed ID: 27022133
[TBL] [Abstract][Full Text] [Related]
39. [The role of omics in precision nutrition: strengths and weaknesses].
Corella D; Ordovás JM
Nutr Hosp; 2018 Jun; 35(Spec No4):10-18. PubMed ID: 30070116
[TBL] [Abstract][Full Text] [Related]
40. Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope.
Aghaei Meybodi HR; Hasanzad M; Larijani B
Acta Med Iran; 2017 Mar; 55(3):166-174. PubMed ID: 28282717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
